Edition:
India

Michael Erman

U.S. hospitals slash use of drug championed by Trump as coronavirus treatment

29 May 2020

NEW YORK U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks.

U.S. hospitals slash use of drug championed by Trump as coronavirus treatment

29 May 2020

NEW YORK, May 29 U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks.

Merck to buy Austrian vaccine maker as it jumps into COVID-19 race

27 May 2020

CHICAGO Merck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines. | Video

Merck leaps into COVID-19 development fray with vaccine, drug deals

26 May 2020

By Julie Steenhuysen and Michael Erman CHICAGO Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.

Merck leaps into COVID-19 development fray with vaccine, drug deals

26 May 2020

By Julie Steenhuysen and Michael Erman CHICAGO Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.

Merck leaps into COVID-19 development fray with vaccine, drug deals

26 May 2020

CHICAGO, May 26 Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.

Drug touted by Trump to treat COVID-19 linked to higher death risk - study

23 May 2020

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed. | Video

Trump administration signs up new company to make COVID-19 drugs in U.S.

20 May 2020

U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.

Trump administration awards contract to make COVID-19 drugs in U.S.

19 May 2020

By Michael Erman and Ankur Banerjee U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.

Pfizer to launch late stage DMD gene therapy trial despite hospitalizations

15 May 2020

By Michael Erman NEW YORK Pfizer Inc said on Friday that a third patient had to be hospitalized after being treated with its experimental gene therapy for a rare degenerative muscular condition, but said the safety profile still supports launching a larger late-stage trial of the treatment.

World News